Roivant Sciences Ltd. (ROIV) Tops Q4 EPS by 16c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q4 EPS of ($0.20), $0.16 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $27.38 million versus the consensus estimate of $18.2 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Pfizer lung cancer drug misses survival goal in Phase 3 trial